14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
LFST vs RNW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, ReNew Energy Global plc Class A (RNW) is the stronger overall head-to-head candidate over LifeStance Health Group, Inc. (LFST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). LFST carries a Unified Composite Score of 36.9/100 (SELL) at $13.82 (30.8x Forward P/E, 6.4% operating margin), whereas RNW carries 55.6/100 (HOLD) at $6.88 (30.3x Forward P/E, 46.7% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LFST vs RNW. Trailing 12-month operating profitability (LFST 6.4% vs RNW 46.7%) and valuation multiples (LFST 30.8x vs RNW 30.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $5.1B market capitalization and 6.4% operating margin.
OpEx & R&D Reinvestment28.0% of Rev ($470M)
90D Engineering Disclosures0 Published
RNW Moat ProfileHigh-Margin Pricing Power Moat
Utilities - Renewable Operator
Competes within the Utilities - Renewable value chain with $2.5B market capitalization and 46.7% operating margin.
OpEx & R&D Reinvestment35.4% of Rev ($585M)
90D Engineering Disclosures0 Published
Investor FAQ LFST vs RNW Key Questions & Quantitative Answers
As of Nov 20, 2026, ReNew Energy Global plc Class A (RNW) is the stronger overall head-to-head candidate over LifeStance Health Group, Inc. (LFST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). LFST carries a Unified Composite Score of 36.9/100 (SELL) at $13.82 (30.8x Forward P/E, 6.4% operating margin), whereas RNW carries 55.6/100 (HOLD) at $6.88 (30.3x Forward P/E, 46.7% operating margin). Technically, LFST sits in a Markup phase (RSI 53.6, UNCLASSIFIED options structure) and RNW sits in a Neutral phase (RSI 41.3, CONSOLIDATION options structure).
RNW leads the Growth & Scale pillar: LFST posts +25.3% YoY revenue growth and N/A YoY earnings growth on $1.68B TTM revenue (34.4% gross margin, 6.4% operating margin), compared with RNW at +28.2% YoY revenue growth and +42.5% YoY earnings growth on $1.65B TTM revenue (82.1% gross margin, 46.7% operating margin). On trailing 12-month operating scale, LFST generates $1.68B in USD-normalized revenue versus $1.65B for RNW. In operating R&D and SG&A reinvestment, LFST deploys 28.0% of Rev ($470M) (0 90-day corporate R&D disclosures) versus 35.4% of Rev ($585M) (0 disclosures) for RNW.
RNW screens cheaper on headline valuation multiples. LFST trades at 30.8x Forward P/E, 74.1x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (9.8% EBITDA margin), whereas RNW trades at 30.3x Forward P/E, 18.2x Trailing P/E, N/M PEG, and 6.9x EV/Revenue (-2.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LFST (4.8% ROE) versus RNW (8.6% ROE) capital efficiency.
In options market volatility and institutional positioning, LFST carries 42.6% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 45% Vol realized risk). By comparison, RNW carries 0.3% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.60β · 4% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.